nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of the clinical antibacterial and antituberculosis pipeline
|
Theuretzbacher, Ursula |
|
|
19 |
2 |
p. e40-e50 |
artikel |
2 |
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration
|
Vekemans, Johan |
|
|
19 |
2 |
p. 123-125 |
artikel |
3 |
A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study
|
Westphal, Darren W |
|
|
19 |
2 |
p. 177-184 |
artikel |
4 |
Attributable deaths caused by infections with antibiotic-resistant bacteria in France
|
Raoult, Didier |
|
|
19 |
2 |
p. 128-129 |
artikel |
5 |
Attributable deaths caused by infections with antibiotic-resistant bacteria in France – Authors' reply
|
Cassini, Alessandro |
|
|
19 |
2 |
p. 129-130 |
artikel |
6 |
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study
|
Whitworth, Hilary S |
|
|
19 |
2 |
p. 193-202 |
artikel |
7 |
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial
|
Kandasamy, Rama |
|
|
19 |
2 |
p. 156-164 |
artikel |
8 |
Correction to Lancet Infect Dis 2019; 19: 193–202
|
|
|
|
19 |
2 |
p. e39 |
artikel |
9 |
Correction to Lancet Infect Dis 2018; 18: 1097–107
|
|
|
|
19 |
2 |
p. e39 |
artikel |
10 |
Correction to Lancet Infect Dis 2018; published online Dec 14. https://doi.org/10.1016/S1473-3099(18)30541-3
|
|
|
|
19 |
2 |
p. e39 |
artikel |
11 |
Dengue pre-vaccination screening and positive predictive values
|
Rodríguez-Barraquer, Isabel |
|
|
19 |
2 |
p. 132-134 |
artikel |
12 |
Dengue rises in Bangladesh
|
Cousins, Sophie |
|
|
19 |
2 |
p. 138 |
artikel |
13 |
Drugs and vaccines in the 21st century for neglected diseases
|
Ferreira, Leonardo L G |
|
|
19 |
2 |
p. 125-127 |
artikel |
14 |
Enhancing immune responses to oral vaccines: still an enigma
|
Sack, David A |
|
|
19 |
2 |
p. 122-123 |
artikel |
15 |
Familiar barriers still unresolved—a perspective on the Zika virus outbreak research response
|
Koopmans, Marion |
|
|
19 |
2 |
p. e59-e62 |
artikel |
16 |
Fuelling the Global Fund
|
The Lancet Infectious Diseases, |
|
|
19 |
2 |
p. 113 |
artikel |
17 |
Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness
|
Lechner, Matt |
|
|
19 |
2 |
p. 131-132 |
artikel |
18 |
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
|
Hemelaar, Joris |
|
|
19 |
2 |
p. 143-155 |
artikel |
19 |
Global molecular epidemiology of HIV-1: the chameleon challenge
|
Paraskevis, Dimitrios |
|
|
19 |
2 |
p. 114-115 |
artikel |
20 |
Harassment and the future of UNAIDS
|
Cousins, Sophie |
|
|
19 |
2 |
p. 137 |
artikel |
21 |
Highlights from ESCAIDE 2018
|
Hall, Phoebe |
|
|
19 |
2 |
p. 139 |
artikel |
22 |
HIV and gender justice in South African contexts
|
Shefer, Tamara |
|
|
19 |
2 |
p. 142 |
artikel |
23 |
Incomplete use of global data for aetiological attribution of diarrhoeal disease in the Global Burden of Disease study
|
Lopman, Ben |
|
|
19 |
2 |
p. 128 |
artikel |
24 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
19 |
2 |
p. 140 |
artikel |
25 |
Interventions to improve oral vaccine performance: a systematic review and meta-analysis
|
Church, James A |
|
|
19 |
2 |
p. 203-214 |
artikel |
26 |
Low anti-rubella antibody levels in public facilities staff in Tokyo
|
Matsunaga, Teiichi |
|
|
19 |
2 |
p. 132 |
artikel |
27 |
Multidrug-resistant tuberculosis outbreak in South Africa
|
Ismail, Nazir A |
|
|
19 |
2 |
p. 134-135 |
artikel |
28 |
Multidrug-resistant tuberculosis outbreak in South Africa – Authors' reply
|
Makhado, Ndivhuho A |
|
|
19 |
2 |
p. 135-136 |
artikel |
29 |
Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report
|
Fields, Virgie S |
|
|
19 |
2 |
p. 185-192 |
artikel |
30 |
Mumps outbreaks in ethnic subpopulations: what can we learn?
|
Westphal, Darren W |
|
|
19 |
2 |
p. 119-120 |
artikel |
31 |
New developments on interferon-γ release assays for tuberculosis diagnosis
|
Arend, Sandra M |
|
|
19 |
2 |
p. 121-122 |
artikel |
32 |
Pneumococcal vaccines in Nepal
|
Russell, Fiona M |
|
|
19 |
2 |
p. 115-116 |
artikel |
33 |
Pseudohernia preceding disseminated herpes zoster
|
Fujikawa, Tatsuya |
|
|
19 |
2 |
p. 215 |
artikel |
34 |
Research brief
|
Mohammadi, Dara |
|
|
19 |
2 |
p. 141 |
artikel |
35 |
Retinal maculopathy in an adult with yellow fever
|
Zin, Olivia Araujo |
|
|
19 |
2 |
p. 216 |
artikel |
36 |
Socioeconomic disparities and infection: it's complicated
|
Gibney, Katherine B |
|
|
19 |
2 |
p. 116-117 |
artikel |
37 |
Socioeconomic disparities associated with 29 common infectious diseases in Sweden, 2005–14: an individually matched case-control study
|
Pini, Alessandro |
|
|
19 |
2 |
p. 165-176 |
artikel |
38 |
Strategies to improve detection and management of human parechovirus infection in young infants
|
Kadambari, Seilesh |
|
|
19 |
2 |
p. e51-e58 |
artikel |
39 |
The changing epidemiology of mumps in a high vaccination era
|
Marshall, Helen S |
|
|
19 |
2 |
p. 118-119 |
artikel |
40 |
Understanding HIV and hepatitis C virus risk among incarcerated young men with histories of injecting drug use
|
Walker, Shelley |
|
|
19 |
2 |
p. 130-131 |
artikel |
41 |
Vaccine-derived poliovirus cases exceed wild types
|
Burki, Talha |
|
|
19 |
2 |
p. 140 |
artikel |